Clare Pratt

Clare has experience in the prosecution of European patent applications, the coordination and management of complex worldwide patent portfolios, and performing and monitoring complex freedom to operate analysis and opinions. Clare has also been involved in providing intellectual property (IP) strategy advice and drafting UK, European, and PCT patent applications.

Clare’s technical expertise includes subject matter relating to gene therapies, gene editing, stem cell therapies, protein therapies, antibodies, diagnostics, and sequencing technologies.

Clare is a European Patent Attorney and Chartered UK Patent Attorney. She also holds a Postgraduate Certificate in Intellectual Property Law with distinction from Queen Mary, University of London.

Clare joined Mathys & Squire after receiving a first class degree in genetics and a PhD at the University of Liverpool. Over the course of her degree, Clare studied a broad range of subjects including immunology, oncology, virology, infectious diseases, medical genetics and cytogenetics, molecular biology, and biochemistry. Her doctoral research surrounded laminopathy-musculoskeletal disorders, stem cells, circadian rhythms, and mechano-biology, and focused on uncovering a novel mechanism of circadian clock regulation in musculoskeletal stem cells by the nuclear lamina as a tool for tissue regeneration and homeostasis. During her PhD, Clare completed a placement at a major pharmaceutical corporation, working in their in-house patent department; there she developed a practical approach to IP.

Clare is a member of the European Patent Institute (EPI) and a fellow of the Chartered Institute of Patent Attorneys (CIPA).